LCM
PASG icon

Laurion Capital Management’s Passage Bio PASG Stock Holding History

Laurion Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,743
Closed -$356K – 649
2022
Q1 		$356K Buy
+5,743
New +$473K ﹤0.01% 419

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laurion Capital Management's PASG Position: Q2 2022 in Review

Laurion Capital Management sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 5,743 shares — an estimated $356K sold.

Laurion Capital Management first reported a position in PASG in Q1 2022 and held it in 1 quarter. The position peaked at $356K in Q1 2022. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Laurion Capital Management reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Laurion Capital Management sold 5,743 Passage Bio shares in Q2 2022, an estimated $356K.
  • Laurion Capital Management first reported a position in Passage Bio in Q1 2022 and held it in 1 quarter.
  • Laurion Capital Management's Passage Bio position peaked at $356K in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.